If you need to understand the offering of a competitor, the scope of a solution, or the value of a potential acquisition, we have experience working both within the life sciences and with those looking to invest in it.

Our analysis can range from a strategic partner sitting to discuss an option, summarising the literature and health economic evidence, conducting interviews with KOLs, to conducting expert user or end-prescriber evaluations at targeted conferences.